Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children

Endocrine Journal

Volumn 52, Issue 5, 2005, Pages 519-524

  Zou, Chao Chun ^a   Liang, Li ^a   Hong, Fang ^a   Fu, Jun Feng ^a   Zhao, Zheng Yan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adiponectin; Child; Non alcoholic fatty liver disease (NAFLD); Obesity; Resistin

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL; URIC ACID;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NONALCOHOLIC FATTY LIVER; OBESITY; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VARIANCE;

ADIPONECTIN; ADOLESCENT; BODY MASS INDEX; CHILD; FATTY LIVER; FEMALE; HUMANS; MALE; OBESITY; PUBERTY; REGRESSION ANALYSIS; RESISTIN;

EID: 27744452634     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.52.519     Document Type: Article

References (33)

1. Takahashi N, Qi Y, Patel HR, Ahima RS (2004) A novel aminosterol reverses diabetes and fatty liver disease in obese mice. J Hepatol 41: 391-398.
2. Cortez-Pinto H, Camilo ME (2004) Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/ NASH): diagnosis and clinical course. Best Pract Res Clin Gastroenterol 18: 1089-1104.
3. Grant LM, Lisker-Melman M (2004) Nonalcoholic fatty liver disease. Ann Hepatol 3: 93-99.
4. Bugianesi E, Marzocchi R, Villanova N, Marchesini G (2004) Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Pract Res Clin Gastroenterol 18: 1105-1116.
5. Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD (2004) Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol 41: 943-949.
6. Videla LA, Rodrigo R, Araya J, Poniachik J (2004) Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic Biol Med 37: 1499-1507.
7. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D (2004) Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 191: 2120-2124.
8. Fasshauer M, Paschke R, Stumvoll (2004) Adiponectin, obesity, and cardiovascular disease. Biochimie 86: 779-784.
9. Higashiura K, Ura N, Ohata J, Togashi N, Takagi S, Saitoh S, Murakami H, Takagawa Y, Shimamoto K (2004) Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol (Oxf) 61:753-759.
10. Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakane T, Kodera K, Shirahata A, Taniyama M (2003) Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 11: 1072-1079.
11. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409: 307-312.
12. Fujita H, Fujishima H, Morii T, Koshimura J, Narita T, Kakei M, Ito S (2002) Effect of metformin on adipose tissue resistin expression in db/db mice. Biochem Biophys Res Commun 298: 345-349.
13. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhou Q, Considine RV (2003) Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 88: 5452-5455.
14. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros CS (2003) Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88: 4848-4856.
15. Beltowski J (2003) Adiponectin and resistin - new hormones of white adipose tissue. Med Sci Monit 9: RA55-61.
16. Roberts EA (2002) Steatohepatitis in children. Best Pract Res Clin Gastroenterol 16: 749-765.
17. Dixon JB, Bhathal PS, O'Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121: 91-100.
18. Loguercio C, De-Girolamo V, de-Sio I, Tuccillo C, Ascione A, Baldi F, Budillon G, Cimino L, Di Carlo A, Di Marino MP, Morisco F, Picciotto F, Terracciano L, Vecchione R, Verde V, Del Vecchio Blanco C (2001) Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 35: 568-574.
19. Nanda K (2004) Non-alcoholic steatohepatitis in children. Pediatr Transplant 8: 613-618.
20. Day CP (2004) The potential role of genes in nonalcoholic fatty liver disease. Clin Liver Dis 8: 673-691.
21. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40: 46-54.
22. Day CP (2004) The potential role of genes in nonalcoholic fatty liver disease. Clin Liver Dis 8: 673-691.
23. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ (2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40: 185-194.
24. Chachkhiani I, Gurlich R, Maruna P, Frasko R, Lindner J (2004) The postoperative stress response and its reflection in cytokine network and leptin plasma levels. Physiol Res [Epub ahead of print]
25. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351: 2599-2610.
26. Ding WX, Yin XM (2004) Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med 8: 445-454.
27. Youssef WI, McCullough AJ (2002) Steatohepatitis in obese individuals. Best Pract Res Clin Gastroenterol 16: 733-747.
28. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850.
29. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278: 9073-9085.
30. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278: 40352-40363.
31. Tsao TS, Lodish HF, Fruebis J (2002) ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 440: 213-221.
32. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y (2004) Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94: e27-31.
33. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279: 12152-12162.